Cell & Gene

Access our end-to-end cell & gene therapy services supporting drug developers at every stage of their journey. As a leading 

Contract Development and Manufacturing Organization (CDMO) in CGT, we provide comprehensive solutions that accelerate 

the development, manufacturing and commercialization of life-changing therapies.

Our cell and gene therapy expertise covers a wide range of modalities, including autologous and allogeneic T-cell therapies 

(CAR-T, TCR, Treg), NK cells, Viral Vectors (LVV, AAV, Adeno, Oncolytic) iPSCs, HSCs, MSCs, Exosome (Extracellular vesicle)-

based therapies, Dendritic cells and more.

Overview

Our experienced team of scientists and engineers work closely with you to ensure seamless project execution and regulatory 

compliance. We are committed to delivering high-quality products and services that meet your exacting specifications and timelines.

Choose Lonza as your CDMO partner for your cell and gene therapy development and manufacturing needs. Contact us today to 

learn more about our services and how we can help bring your therapy to market faster.

Our state-of-the-art facilities and high quality control processes also ensure that your product is manufactured to the highest standards.

견적 문의: aibiohub@aibiohub.co.kr  홈페이지: www.aibiohub.co.kr 

견적 문의: https://aibiohub.co.kr/estimate/write